Lipid Testing After Myocardial Infarction at the Montreal Heart Institute

What this study is about

Because treatment decisions are usually based on a single measurement of the lipid panel at the time of an admission for an MI, the overarching objective of this project is to evaluate whether the measurement of LDL, non-HDL, and apoB values are reliable through all the duration of the hospitalization. It will be a single-center, prospective, observational study will be conducted, including consecutive patients hospitalized for myocardial infarction at the Montreal Heart Institute. Every patient at the Cardiac Care Unit will undergo non-fasting lipid panel testing at day 0 of their admission for Myocardial Infarction during the study period. Patients who consent to participate will have a 2nd non-fasting lipid panel drawn at day 2 of their admission. Thereafter, the levels of the different lipid values from the panel will be compared between day 0, day 2, and 4-6 weeks after discharge.

Who can join (things the study team will check)

✅ You may be able to join if…

• Adult patients ≥18 years old
• Hospitalized at the Cardiac Care Unit for Myocardial Infarction (either NSTEMI or STEMI)
• Lipid panel performed on day 0 of admission
• Willing to provide informed consent

🚫 You may not be able to join if…

• None

Where this trial is running

• Montreal Heart Institute, Montreal, Quebec, Canada
• Montreal Heart Institute, Montreal, Quebec, Canada

Who to contact

Suzy Otis · (514) 376-3330 · suzy.otis@icm-mhi.org

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT06388668.